References
- Annertz K, Anderson H, Palmer K, et al. The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty-first century. Acta Oto-Laryngologica. 2012;132(5):552–557.
- Hammarstedt L, Lu Y, Marklund L, et al. Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol. 2011;47(7):636–641.
- Mroueh R, Haapaniemi A, Grenman R, et al. Improved outcomes with oral tongue squamous cell carcinoma in Finland. Head Neck. 2017;39(7):1306–1312.
- D'Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373(6):521–529.
- Kamali A, Gahm C, Palmgren B, et al. Regional recurrence in early stage I-II oral tongue cancer: a single institutional study and review of the literature. Acta Oto-Laryngologica. 2017;137(7):755–761.
- Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010;28(8):1395–1400.
- Agrawal A, Civantos FJ, Brumund KT, et al. [(99m)Tc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol. 2015;22(11):3708–3715.
- Schilling C, Stoeckli SJ, Haerle SK, et al. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer. 2015;51(18):2777–2784.
- Sowder JC, Cannon RB, Buchmann LO, et al. Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: a population-based study. Head Neck. 2017;39(5):876–880.
- Gogarty DS, Lennon P, Deady S, et al. Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2017;274(2):953–960.
- Ji YB, Cho YH, Song CM, et al. Long-term functional outcomes after resection of tongue cancer: determining the optimal reconstruction method. Eur Arch Otorhinolaryngol. 2017;274(10):3751–3756.
- Subramaniam N, Balasubramanian D, Murthy S, et al. Adverse pathologic features in early oral squamous cell carcinoma and the role of postoperative radiotherapy-a review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(1):24–31.
- Ansarin M, Bruschini R, Navach V, et al. Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck. 2019;41(3):821–827.
- Lu CC, Tsou YA, Hua CH, et al. Free flap reconstruction for early stage tongue squamous cell carcinoma: surgical margin and recurrence. Acta Oto-Laryngologica. 2018;138(10):945–950.
- McConnel FM, Pauloski BR, Logemann JA, et al. Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing. Arch Otolaryngol Head Neck Surg. 1998;124(6):625–630.
- Lee DY, Ryu YJ, Hah JH, et al. Long-term subjective tongue function after partial glossectomy. J Oral Rehabil. 2014;41(10):754–758.
- Canis M, Weiss BG, Ihler F, et al. Quality of life in patients after resection of pT3 lateral tongue carcinoma: microvascular reconstruction versus primary closure. Head Neck. 2016;38(1):89–94.
- Sun J, Weng Y, Li J, et al. Analysis of determinants on speech function after glossectomy. J Oral Maxillofacial Surg. 2007;65(10):1944–1950.
- Ojo B, Genden EM, Teng MS, et al. A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol. 2012;48(10):923–937.
- Kansy K, Mueller AA, Mucke T, et al. A worldwide comparison of the management of T1 and T2 anterior floor of the mouth and tongue squamous cell carcinoma – extent of surgical resection and reconstructive measures. J Cranio-Maxillo-Facial Surg. 2017;45(12):2097–2104.